Literature DB >> 28652252

Glycerol-3-phosphate Acyltransferase 1 Promotes Tumor Cell Migration and Poor Survival in Ovarian Carcinoma.

Rosemarie Marchan1, Bettina Büttner2, Jörg Lambert3, Karolina Edlund2, Iris Glaeser2, Meinolf Blaszkewicz2, Gregor Leonhardt2, Lisa Marienhoff2, Darius Kaszta2, Moritz Anft4, Carsten Watzl4, Katrin Madjar5, Marianna Grinberg5, Eugen Rempel6, Roland Hergenröder3, Silvia Selinski2, Jörg Rahnenführer5, Michaela S Lesjak7, Joanna D Stewart8, Cristina Cadenas2, Jan G Hengstler2.   

Abstract

Glycerophosphodiesterase EDI3 (GPCPD1; GDE5; GDPD6) has been suggested to promote cell migration, adhesion, and spreading, but its mechanisms of action remain uncertain. In this study, we targeted the glycerol-3-phosphate acyltransferase GPAM along with choline kinase-α (CHKA), the enzymes that catabolize the products of EDI3 to determine which downstream pathway is relevant for migration. Our results clearly showed that GPAM influenced cell migration via the signaling lipid lysophosphatidic acid (LPA), linking it with GPAM to cell migration. Analysis of GPAM expression in different cancer types revealed a significant association between high GPAM expression and reduced overall survival in ovarian cancer. Silencing GPAM in ovarian cancer cells decreased cell migration and reduced the growth of tumor xenografts. In contrast to these observations, manipulating CHKA did not influence cell migration in the same set of cell lines. Overall, our findings show how GPAM influences intracellular LPA levels to promote cell migration and tumor growth. Cancer Res; 77(17); 4589-601. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28652252     DOI: 10.1158/0008-5472.CAN-16-2065

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  Targeting USP7 Identifies a Metastasis-Competent State within Bone Marrow-Resident Melanoma CTCs.

Authors:  Monika Vishnoi; Debasish Boral; Haowen Liu; Marc L Sprouse; Wei Yin; Debalina Goswami-Sewell; Michael T Tetzlaff; Michael A Davies; Isabella C Glitza Oliva; Dario Marchetti
Journal:  Cancer Res       Date:  2018-07-19       Impact factor: 12.701

2.  Highlight report: The EDI3-GPAM axis in tumor cell migration.

Authors:  Reham Hassan
Journal:  EXCLI J       Date:  2017-10-19       Impact factor: 4.068

3.  Highlight report: Import of fatty acids by metastasizing tumor cells.

Authors:  Tim Brecklinghaus
Journal:  EXCLI J       Date:  2018-11-19       Impact factor: 4.068

4.  LIPG supports adaption to oxidative stress.

Authors:  Gregor Leonhardt
Journal:  EXCLI J       Date:  2019-07-10       Impact factor: 4.068

5.  Highlight report: Role of PD-L1 in never-smokers.

Authors:  Wiebke Albrecht
Journal:  EXCLI J       Date:  2019-06-18       Impact factor: 4.068

6.  Role of WDR5 in breast cancer prognosis.

Authors:  Regina Stoeber
Journal:  EXCLI J       Date:  2019-12-16       Impact factor: 4.068

7.  Highlight report: Role of choline phospholipid metabolism in tumor progression.

Authors:  Wiebke Albrecht
Journal:  EXCLI J       Date:  2019-12-19       Impact factor: 4.068

8.  Tumor suppressor role of genes involved in circadian clock control.

Authors:  Reham Hassan
Journal:  EXCLI J       Date:  2019-12-19       Impact factor: 4.068

9.  Highlight report: Intratumoral metabolomic heterogeneity of breast cancer.

Authors:  Regina Stoeber
Journal:  EXCLI J       Date:  2017-12-22       Impact factor: 4.068

10.  High-Dose Dexamethasone Manipulates the Tumor Microenvironment and Internal Metabolic Pathways in Anti-Tumor Progression.

Authors:  Lei Xu; Hua Xia; Dongsheng Ni; Yanxia Hu; Jianing Liu; Yao Qin; Qin Zhou; Qiying Yi; Yajun Xie
Journal:  Int J Mol Sci       Date:  2020-03-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.